Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?: A population level view in the EHR-based RECOVER program

Mostrar otras versiones (1)

Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include an increased incidence of diabetes. Our objective was to describe the temporal relationship between new diagnoses of diabetes mellitus and SARS-CoV-2 infection in a nationally representative database. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Neha V, Yeh, Hsin-Chieh, Tronieri, Jena S, Stürmer, Til, Buse, John B, Reusch, Jane E, Johnson, Steven G, Wong, Rachel, Moffitt, Richard, Wilkins, Kenneth J, Harper, Jeremy, Bramante, Carolyn T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727757/
https://www.ncbi.nlm.nih.gov/pubmed/36482974
http://dx.doi.org/10.1101/2022.12.02.22283029
Descripción
Sumario:Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include an increased incidence of diabetes. Our objective was to describe the temporal relationship between new diagnoses of diabetes mellitus and SARS-CoV-2 infection in a nationally representative database. There appears to be a sharp increase in diabetes diagnoses in the 30 days surrounding SARS-CoV-2 infection, followed by a decrease in new diagnoses in the post-acute period, up to 360 days after infection. These results underscore the need for further investigation, as understanding the timing of new diabetes onset after COVID-19 has implications regarding potential etiology and screening and treatment strategies.

Ejemplares similares